Journal of the Formosan Medical Association
Volume 107, Issue 10 , Pages 798-805, October 2008

T2-weighted and T1-weighted Dynamic Superparamagnetic Iron Oxide (Ferucarbotran) Enhanced MRI of Hepatocellular Carcinoma and Hyperplastic Nodules

  • Ran-Chou Chen

      Affiliations

    • Department of Radiology, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan
    • Department of Biomedical Imaging and Radiological Science, National Yang-Ming Medical University, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Ran-Chou Chen, Department of Biomedical Imaging and Radiological Science, National Yang-Ming Medical University, 155, Section 2, Linong Street, Taipei 112, Taiwan
    • ,
  • Jiunn-Ming Lii

      Affiliations

    • Department of Radiology, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan
    • ,
  • Chen-Te Chou

      Affiliations

    • Department of Biomedical Imaging and Radiological Science, National Yang-Ming Medical University, Taipei, Taiwan
    • Department of Medical Imaging, Changhua Christian Hospital, Changhua, Taiwan
    • ,
  • Ting-An Chang

      Affiliations

    • Department of Pathology, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan
    • ,
  • Wei-Tsung Chen

      Affiliations

    • Department of Radiology, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan
    • ,
  • Chao-Shiang Li

      Affiliations

    • Department of Radiology, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan
    • ,
  • Hsing-Yang Tu

      Affiliations

    • Department of Radiology, Taipei City Hospital Ren-Ai Branch, Taipei, Taiwan

Received 30 January 2008; received in revised form 10 April 2008; accepted 15 May 2008.

Article Outline

Background/Purpose

Iron oxide contrast medium (ferucarbotran) shortens both T1 and T2 relaxation time. We used the T2- and the T1-weighted dynamic ferucarbotran-enhanced magnetic resonance (MR) imaging to predict the histologic grade of hepatocellular carcinoma (HCC) and to distinguish HCC from hyperplastic nodules.

Methods

Forty-three patients with 48 representative hepatic lesions (13 well differentiated HCC, 19 moderately differentiated HCC, 4 poorly differentiated HCC, 12 hyperplastic nodules) were included in the study. T1-weighted image, T2-weighted turbo spin echo, and T2*EPI (echo-planar) images were obtained before and after ferucarbotran injection. The percentage T2 signal intensity loss (T2 PSIL) of the tumors was calculated at 5 minutes and 25 minutes after contrast injection. The enhancement in dynamic T1 images was interpreted by two independent radiologists.

Results

The T2 PSIL of well differentiated HCC was 39.5 ± 8.23%, moderately differentiated HCC was 26.4 ± 13.78%, poorly differentiated HCC was 4.4 ± 9.42%, and hyperplastic nodules was 44.3 ± 11.04%. Comparison of T2 PSIL showed significant differences in the three histologically graded HCCs (p < 0.001), but not between the well differentiated HCCs and hyperplastic nodules (p > 0.05). Delayed post-contrast (25 minutes) T2-weighted images were not necessary and shortened the examination time. In the post contrast dynamic T1 study, no significant differences between all the groups was seen.

Conclusion

Ferucarbotran MR images help in differentiating the different histologic grades of HCC but T2 PSIL could not differentiate hyperplastic nodules from well differentiated HCC. Dynamic post contrast T1-weighted images provide no additional information.

Key Words:  hepatocellular carcinoma , hyperplasia , liver cell adenoma , magnetic resonance , ultrasmall superparamagnetic iron oxide

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Matsui O , Kadoya M , Kameyama T , et al.   Benign and malignant nodules in cirrhotic livers: distinction based on blood supply . Radiology . 1991;178:493–497
  2. Blakeborough A , Ward J , Wilson D , et al.   Hepatic lesion detection at MR imaging: a comparative study with four sequences . Radiology . 1997;203:756–765
  3. Kang BK , Lim JH , Kim SH , et al.   Preoperative depiction of hepatocellular carcinoma: ferumoxide-enhanced MR imaging versus triple-phase helical CT . Radiology . 2003;226:79–85
  4. Kim SH , Choi D , Kim SH , et al.   Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma . AJR Am J Roentgenol . 2005;184:1069–1076
  5. Lencioni R , Della Pina C , Bruix J , et al.   Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography . Dig Dis Sci . 2005;50:533–537
  6. Tanimoto A , Kuribayashi S . Application of superparamagnetic iron oxide to imaging of hepatocellular carcinoma . Eur J Radiol . 2006;58:200–216
  7. Tanaka M , Nakashima O , Wada Y , et al.   Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver . Hepatology . 1996;24:807–812
  8. Kawamori Y , Matsui O , Kadoya M , et al.   Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging . Radiology . 1992;183:65–72
  9. Imai Y , Murakami T , Yoshida S , et al.   Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading . Hepatology . 2000;32:205–212
  10. Reimer P , Balzer T . Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications . Eur Radiol . 2003;13:1266–1276
  11. Roncalli M . Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience . Liver Transpl . 2004;10:S9–15
  12. Kojiro M . Focus on dysplastic nodules and early hepato-cellular carcinoma: an Eastern point of view . Liver Transpl . 2004;10:S3–S8
  13. Kojiro M . Histopathology of liver cancers . Best Pract Res Clin Gastroenterol . 2005;19:39–62
  14. Hamilton SR , Aaltonen LA . Pathology and genetics of tumours of the digestive system . In: WHO Classification of Tumours . 1st edition. USA: Oxford University Press; 2001;p. 165–166
  15. Tang Y , Yamashita Y , Arakawa A , et al.   Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging . AJR Am J Roentgenol . 1999;172:1547–1554
  16. Takeshita K , Nagashima I , Frui S , et al.   Effect of super-paramagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperpastic nodule . J Comput Assist Tomogr . 2002;26:451–455
  17. Chen RC , Wang CK , Wang CS , et al.   Depiction of vasculature in small hepatocellular carcinoma, and dysplastic nodules evaluated with carbon dioxide ultrasonography and angiography . Acta Radiologica . 2002;43:66–70
  18. Kato H , Kanematsu M , Kondo H , et al.   Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity . J Magn Reson Imaging . 2004;19:76–81
  19. Li CS , Chen RC , Tu HY , et al.   Imaging well-differentiated hepatocellular carcinoma with dynamic triple-phase helical computed tomography . Br J Radiol . 2006;79:659–665
  20. Li CS , Chen RC , Jiunn-Ming Lii , et al.   Magnetic resonance imaging appearance of well-differentiated hepatocellular carcinoma . J Comput Assist Tomogr . 2006;30:597–603
  21. Zhang XH , Liang BL , Huang SQ . Correlation between SPIO-enhanced magnetic resonance imaging (MRI) and histological grading in hepatocellular carcinoma . Ai Zheng . 2003;22:734–738
  22. Tarimoto A , Yuasa Y , Shinmoto H , et al.   Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function . Radiology . 2002;222:661–666
  23. Macarini L , Marini S , Murrone M , et al.   Alterations in hepatic uptake and distribution of organ-specific superparamagnetic MRI contrast media: clinical findings and classification according to pathogenesis . Radiol Med (Torino) . 2004;108:92–106
  24. Stroszczynski C , Gaffke G , Gretshel S , et al.   Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesion: and ROC analysis . Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr . 2003;175:1368–1375
  25. Vogl TJ , Hammerstingl R , Keck H , et al.   Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium . Radiology . 1995;35:258–266
  26. Pauleit D , Textor J , Bachmann R , et al.   Hepatocellular carcinoma: detection with gadolinium- and ferumoxides-enhanced MR imaging of the liver . Radiology . 2003;222:73–80
  27. Lutz AM , Willmann JK , Goepfert K , et al.   Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging . Radiology . 2005;237:520–528

PII: S0929-6646(08)60193-X

doi:10.1016/S0929-6646(08)60193-X

Journal of the Formosan Medical Association
Volume 107, Issue 10 , Pages 798-805, October 2008

Article Tools